Citation: Ta. Lallas et Re. Buller, OPTIMIZATION OF PCR AND ELECTROPHORESIS CONDITIONS ENHANCES MUTATION ANALYSIS OF THE BRCA1 GENE, MOLECULAR GENETICS AND METABOLISM, 64(3), 1998, pp. 173-176
Authors:
DREICER R
LALLAS TA
JOYCE JK
ANDERSON B
SOROSKY JI
BULLER RE
Citation: R. Dreicer et al., VINBLASTINE, IFOSFAMIDE, GALLIUM NITRATE, AND FILGRASTIM IN PLATINUM-RESISTANT AND PACLITAXEL-RESISTANT OVARIAN-CANCER - A PHASE-II STUDY, American journal of clinical oncology, 21(3), 1998, pp. 287-290
Citation: Te. Buekers et al., A NOVEL TECHNIQUE FOR GYNECOLOGIC ONCOLOGY SURGERY IN THE PRESENCE OFABDOMINAL-WALL MESH PROSTHESIS, Gynecologic oncology (Print), 70(1), 1998, pp. 87-89
Citation: Ak. Sood et Re. Buller, DRUG-RESISTANCE IN OVARIAN-CANCER - FROM THE LABORATORY TO THE CLINIC, Obstetrics and gynecology, 92(2), 1998, pp. 312-319
Authors:
SOOD AK
SOROSKY JI
GELDER MS
BULLER RE
ANDERSON B
WILKINSON E
BENDA JA
MORGAN LS
Citation: Ak. Sood et al., PRIMARY OVARIAN SARCOMA - ANALYSIS OF PROGNOSTIC VARIABLES AND THE ROLE OF SURGICAL CYTOREDUCTION, Cancer, 82(9), 1998, pp. 1731-1737
Authors:
BULLER RE
SKILLING JS
SOOD AK
PLAXE S
BAERGEN RN
LAGER DJ
Citation: Re. Buller et al., FIELD CANCERIZATION - WHY LATE RECURRENT OVARIAN-CANCER IS NOT RECURRENT, American journal of obstetrics and gynecology, 178(4), 1998, pp. 641-649
Authors:
BULLER RE
SOOD A
FULLENKAMP C
SOROSKY J
POWILLS K
ANDERSON B
Citation: Re. Buller et al., THE INFLUENCE OF THE P53 CODON-72 POLYMORPHISM ON OVARIAN CARCINOGENESIS AND PROGNOSIS, Cancer gene therapy, 4(4), 1997, pp. 239-245
Authors:
COPPOLA A
SOROSKY J
CASPER R
ANDERSON B
BULLER RE
Citation: A. Coppola et al., THE CLINICAL COURSE OF CERVICAL-CARCINOMA IN-SITU DIAGNOSED DURING PREGNANCY, Gynecologic oncology, 67(2), 1997, pp. 162-165
Authors:
RASMUSSEN CC
SKILLING JS
SOROSKY JI
LAGER DJ
BULLER RE
Citation: Cc. Rasmussen et al., STAGE IIIC OVARIAN LEIOMYOSARCOMA IN A PREMENOPAUSAL WOMAN WITH MULTIPLE RECURRENCES - PROLONGED SURVIVAL WITH SURGICAL THERAPY, Gynecologic oncology, 66(3), 1997, pp. 519-525
Authors:
SOOD AK
BULLER RE
BURGER RA
DAWSON JD
SOROSKY JI
BERMAN M
Citation: Ak. Sood et al., VALUE OF PREOPERATIVE CA-125 LEVEL IN THE MANAGEMENT OF UTERINE-CANCER AND PREDICTION OF CLINICAL OUTCOME, Obstetrics and gynecology, 90(3), 1997, pp. 441-447
Citation: Ak. Sood et Re. Buller, GENOMIC INSTABILITY IN OVARIAN-CANCER - A REASSESSMENT USING AN ARBITRARILY PRIMED POLYMERASE CHAIN-REACTION, Oncogene, 13(11), 1996, pp. 2499-2504
Authors:
MAYR NA
YUH WTC
MAGNOTTA VA
EHRHARDT JC
WHEELER JA
SOROSKY JI
DAVIS CS
WEN BC
MARTIN DD
PELSANG RE
BULLER RE
OBERLEY LW
MELLENBERG DE
HUSSEY DH
Citation: Na. Mayr et al., TUMOR PERFUSION STUDIES USING FAST MAGNETIC-RESONANCE-IMAGING TECHNIQUE IN ADVANCED CERVICAL-CANCER - A NEW NONINVASIVE PREDICTIVE ASSAY, International journal of radiation oncology, biology, physics, 36(3), 1996, pp. 623-633
Authors:
SOOD AK
SOROSKY JI
KROGMAN S
ANDERSON B
BENDA J
BULLER RE
Citation: Ak. Sood et al., SURGICAL-MANAGEMENT OF CERVICAL-CANCER COMPLICATING PREGNANCY - A CASE-CONTROL STUDY, Gynecologic oncology, 63(3), 1996, pp. 294-298
Authors:
SKILLING JS
POWILLS K
LAGER DJ
ANDERSON B
SOROSKY J
BULLER RE
Citation: Js. Skilling et al., P53 ALLELOTYPES AND ENHANCED DETECTION OF ALLELIC LOSS IN OVARIAN-CANCER - LACK OF CORRELATION WITH FAMILIAL AND CLINICAL FACTORS, Gynecologic oncology, 61(2), 1996, pp. 180-188
Authors:
SKILLING JS
SQUATRITO RC
CONNOR JP
NIEMANN T
BULLER RE
Citation: Js. Skilling et al., P53 GENE MUTATION ANALYSIS AND ANTISENSE-MEDIATED GROWTH-INHIBITION OF HUMAN OVARIAN-CARCINOMA CELL-LINES, Gynecologic oncology, 60(1), 1996, pp. 72-80
Authors:
SCHWARTZ PE
ELIAS S
MCDONOUGH PG
BULLER RE",GALLION
Citation: Pe. Schwartz et al., EVIDENCE FOR A UNIFOCAL ORIGIN IN FAMILIAL OVARIAN-CANCER - DISCUSSION, American journal of obstetrics and gynecology, 174(4), 1996, pp. 1106-1108
Citation: Re. Buller et al., CA-125 KINETICS - A COST-EFFECTIVE CLINICAL TOOL TO EVALUATE CLINICAL-TRIAL OUTCOMES IN THE 1990S, American journal of obstetrics and gynecology, 174(4), 1996, pp. 1241-1253